Second investor stakes claim in Rotech
By HME News Staff
Updated Tue July 19, 2011
NEW YORK - Robeco Investment Management owns 1,836,354 shares or 7.15% of Rotech Healthcare's common stock, according to a July 18 Securities and Exchange Commission filing.
The shares are worth $7.99 million, at Rotech's July 18 closing price of $4.35. Robeco holds the shares for Robeco Boston Partners Long/Short Equity Fund of The RBB Fund, Inc.
On June 9, another investor, Wynnefield Capital Management, reported in an SEC filing that it owns 1,682,427 shares or 6.6% of Rotech's common stock.
Rotech announced July 19 that it has completed its registered exchange offer of $283.5 million in aggregate principal of senior second lien notes for an equal amount of its Senior Second Lien Notes due 2018.
Rotech offers home oxygen and other respiratory therapy equipment and services in 48 states through approximately 425 locations.
In May, the company reported revenues of $28.3 million for the first quarter of 2011, a 13.6% increase.
Comments